Infusion services…delivered with expertise.
At Specialized Infusion Therapy at RCCA, all five of our facilities offer the complete range of modern infusion therapies. Whether you’re newly diagnosed and seeking a provider or looking for a new infusion provider, we can help. We bring to your care the experience and professionalism to:
- Ensure you meet the treatment requirements
- Deliver your treatment
- Keep you comfortable
- Handle any special needs
- Monitor your treatment
- Respond to issues that may arise
We have the infusion therapy your doctor prescribed.
Whether or not you are newly diagnosed, you’re looking not just for “infusion therapy” but, rather, infusion of a specific drug therapy and protocol. As a full-service infusion provider, we offer them all. Review the list of drugs below to see for yourself. If you’ve been prescribed a treatment that you don’t see listed, please don’t hesitate to call us. If we don’t have it, we’ll get it, because it’s essential that you get the care you need.
| Drug | Disorders Treated |
| ACTEMRA (Tocilizumab) | Rheumatoid arthritisGiant cell arteritis |
| BENLYSTA (Belimumab) | Lupus |
| BONIVA (Ibandronate) | Osteoporosis in postmenopausal females |
| CIMZIA (Certolizumab pegol) |
Rheumatoid arthritis Psoriatic arthritis Ankylosing spondylitis Plaque psoriasis Crohn’s disease |
| CINQAIR (Reslizumab) | Add-on maintenance treatment of severe asthma with an eosinophilic phenotype |
| ENTYVIO (Vedolizumab) |
Crohn’s disease Ulcerative colitis |
| EVENITY (Romosozumab) | Osteoporosis |
| FASENRA (Benralizumab) | Asthma |
| INFLECTRA (Infliximab-dyyb) |
Rheumatoid arthritisPlaque psoriasis Psoriatic arthritis Ankylosing spondylitis Crohn’s disease Ulcerative colitis Inflammatory bowel arthritis Behçet’s syndrome uveitis Adult stills disease Vasculitis Undifferentiated spondyloarthropathy Pyoderma gangrenosum Other inflammatory diseases |
| IV IRON (Infed, Venofer, Ferrlecit, Injectafer, Feraheme) | Iron-deficiency anemia |
| Immune globulin (IVIG) (Carimune, Gammagard, Octagam, Privigen) |
Chronic inflammatory demyelinating polyneuropathy Immune thrombocytopenia Immunodeficiency syndromes Multifocal motor neuropathy Guillain-Barré syndrome Myasthenia gravis (acute exacerbation) Relapsing-remitting multiple sclerosis |
| KRYSTEXXA (Pegloticase) | Gout |
| NUCALA (Mepolizumab) |
Asthma Eosinophilic granulomatosis with polyangiitis |
| NULOJIX (Belatacept) |
Kidney transplant (de novo use) in adult Epstein-Barr virus (EBV) seropositive kidney transplant recipients Lung transplant organ rejection prophylaxis |
| OCREVUS (Ocrelizumab) | Multiple sclerosis, relapsing or progressive |
| ORENCIA (Abatacept) |
Rheumatoid arthritis Psoriatic arthritis |
| PROLASTIN (alpha-1 proteinase inhibitor) | Alpha 1 proteinase inhibitor deficiency |
| PROLIA (Denosumab) |
Osteoporosis/bone loss Bone destruction caused by rheumatoid arthritis |
| PROVENGE (Sipuleucel-T) | Prostate cancer, metastatic |
| RADICAVA (Edaravone) | Amyotrophic lateral sclerosis (ALS) |
| RECLAST (Zoledronic Acid) | Osteoporosis, prevention, treatment |
| REMICADE (Infliximab) |
Rheumatoid arthritis Plaque psoriasis Psoriatic arthritis Ankylosing spondylitis Crohn’s disease Ulcerative colitis Behçet syndrome uveitis Adult Stills disease Vasculitis Undifferentiated spondyloarthropathy Pyoderma gangrenosum Other inflammatory diseases |
| RITUXAN (Rituximab) |
Rheumatoid arthritis Lupus nephritis Neuromyelitis optica Pemphigus vulgaris Certain autoimmune diseases |
| SIMPONI ARIA (Golimumab) |
Rheumatoid arthritis Psoriatic arthritis Ankylosing spondylitis Ulcerative colitis |
| SOLIRIS (Eculizumab) |
Atypical hemolytic uremic syndrome Generalized myasthenia gravis Neuromyelitis optica |
| STELARA (Ustekinumab) |
Crohn’s disease Plaque psoriasis Psoriatic arthritis |
| TEPEZZA (Teprotumumab) | Thyroid eye disease |
| TYSABRI (Natalizumab) |
Multiple sclerosis Crohn’s disease |
| VYEPTI (Eptinezumab) | Migraine prophylaxis |
| XOLAIR (Omalizumab) |
Asthma Chronic idiopathic urticaria |
For experienced infusion care, ask your physician to refer you to Specialized Infusion Therapy at RCCA. For more information, call 732-390-7750 or contact us using our easy online form.